MENU
VB
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

VB stock forecast, quote, news & analysis

The investment seeks to track the performance of the CRSP U... Show more

Category: #Small Blend
Interact to see
Advertisement
A.I.Advisor
published price charts
VB
Daily Signal:
Gain/Loss:
A.I.Advisor
Nov 01, 2026

Vanguard Small-Cap ETF (VB) ETF Analysis: Industrials and Technology Anchor a Diversified Small-Cap Core

Key Takeaways

  • VB tracks the CRSP US Small Cap Index, a broad benchmark spanning U.S. companies in the lower band of the investable market-capitalization spectrum.
  • The fund holds roughly 1,300 stocks, with industrials (about 20%) and technology (about 18%) as its largest sector weights, followed by financial services and healthcare.
  • VB is passively managed with a 0.03% expense ratio and more than $170 billion in assets under management (AUM), making it one of the largest U.S. small-cap ETFs.
  • Over the trailing 30 days, VB has edged roughly 2% higher, while remaining near flat over the trailing quarter as elevated interest rates kept small-cap momentum in check.
  • Because no single position exceeds about 0.7% of assets, returns are driven by broad sector and macroeconomic forces rather than any individual stock.
  • For additional context on this ETF's outlook, review the latest Price Targets and Forecast pages.
  • Investors can also explore Trending AI Robots to see how AI-driven strategies are approaching the current market environment.

Vanguard Small-Cap ETF (VB) Overview

Vanguard Small-Cap ETF (VB) is a passively managed exchange-traded fund (ETF) that seeks to track the CRSP US Small Cap Index before fees and expenses. The index represents U.S. companies falling roughly between the bottom 2% and 15% of the investable equity market by capitalization, creating a small-cap blend that spans both growth and value profiles. VB uses a full-replication approach, holding stocks in approximately the same proportions as the index.

The portfolio contains more than 1,300 holdings, which limits single-stock risk. Top positions include Credo Technology Group (CRDO), Jabil (JBL), Astera Labs (ALAB), Natera (NTRA), Revolution Medicines (RVMD), and EMCOR Group (EME), each representing well under 1% of assets. Sector exposure is led by industrials (about 20%) and technology (about 18%), with financial services and healthcare each near 12%–13%, followed by consumer cyclical and real estate. The fund carries a net expense ratio of 0.03%.

Industry and Thematic Landscape

Small-cap equities entered a more challenging phase during the latter part of 2026 after outperforming large caps through the first half of the year. The primary headwind has been interest rates: the 10-year U.S. Treasury yield moved above 5%, raising financing costs for smaller companies that rely more heavily on floating-rate debt and external capital. This asymmetry has disproportionately pressured longer-duration and less-profitable small caps even as large-cap leaders remained resilient.

At the same time, the domestic economy has stayed relatively firm. The S&P Global Manufacturing Purchasing Managers' Index reached its strongest reading in more than four years, and labor-market conditions remained broadly stable. Inflation, however, has lingered above target, with the Consumer Price Index (CPI) and core inflation measures keeping policymakers cautious. This combination of resilient activity and sticky inflation has supported cyclical industrial and financial names while restraining rate-sensitive growth segments, shaping a market environment that favors diversified, multi-sector exposure over concentrated bets.

Performance and Positioning Snapshot

VB has been essentially range-bound in recent weeks. Over the trailing 30 days, the fund advanced roughly 2%, while over the trailing quarter it was slightly lower, reflecting the flat performance of the small-cap complex as a whole. This is consistent with broader small-cap benchmarks, which gave back first-half leadership gains as longer-dated yields climbed.

The fund's sector mix helps explain this behavior. Its substantial industrials and technology exposure ties it to domestic manufacturing and the artificial-intelligence build-out, areas where many smaller suppliers of specialized equipment and components have continued to grow. Meanwhile, its healthcare weight includes biotechnology names that are more sensitive to financing conditions, and its financial services exposure remains linked to the path of interest rates. With earnings revisions mixed across the small-cap universe, VB's broad diversification has muted single-stock volatility, leaving macro factors such as Treasury yields and inflation expectations as the dominant drivers of recent performance.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform designed to help investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool enables users to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For those researching diversified small-cap strategies or identifying momentum and value setups across sectors, the screener provides a structured way to narrow the universe. Explore the AI Screener to begin scanning based on your own criteria.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape VB's trajectory over the remainder of 2026 and beyond. Interest-rate policy remains central: additional Federal Reserve tightening would raise financing costs for smaller, more leveraged companies, while a pause or shift toward easing could relieve a key constraint on small-cap valuations. Inflation trends, particularly in energy and services, will influence that path.

Domestic economic growth is another important variable. Because small-cap revenue is heavily concentrated in the United States, VB is closely tied to manufacturing activity, consumer spending, and credit conditions. The artificial-intelligence build-out may continue to benefit specialized industrial and technology suppliers within the fund, though any slowdown in that capital-expenditure cycle would ripple across holdings. Healthcare innovation and biotechnology financing conditions, along with merger and acquisition activity, also represent potential catalysts. Investors should monitor sector rotation, earnings revisions among small-cap constituents, and capital flows into small-cap ETFs as signals of whether the current consolidation gives way to renewed leadership or further range-bound trading.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for VB with price predictions
Nov 02, 2026

Momentum Indicator for VB turns positive, indicating new upward trend

VB saw its Momentum Indicator move above the 0 level on October 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 83 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VB's RSI Oscillator exited the oversold zone, 20 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for VB just turned positive on October 20, 2026. Looking at past instances where VB's MACD turned positive, the stock continued to rise in 46 of 53 cases over the following month. The odds of a continued upward trend are 87%.

VB moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where VB advanced for three days, in 270 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

VB broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VB entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), EQT Corp (NYSE:EQT), Illumina (NASDAQ:ILMN), Centene Corp (NYSE:CNC), Okta (NASDAQ:OKTA), Twilio (NYSE:TWLO), Dow (NYSE:DOW), Incyte Corp (NASDAQ:INCY), Roku (NASDAQ:ROKU), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks to track the performance of the CRSP U.S. Small Cap Index that measures the investment return of small-capitalization stocks. The fund advisor employs an indexing investment approach designed to track the performance of the CRSP U.S. Small Cap Index, a broadly diversified index of stocks of small U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard Morningstar Small-Cap ETF (VB) ETF is 6.8B. The market cap for tickers in the group ranges from 309.86M to 88.16B. MRNA holds the highest valuation in this group at 88.16B. The lowest valued company is CCOI at 309.86M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was 57%. For the same ETF, the average monthly price growth was 136%, and the average quarterly price growth was 371%. ULCC experienced the highest price growth at 51%, while IOVA experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was 21%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 54
Price Growth Rating: 51
SMR Rating: 64
Profit Risk Rating: 74
Seasonality Score: 13 (-100 ... +100)